1-20 of 106
Elena Zamagni
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treatment with Daratumumab Plus Bortezomib, Cyclophosphamide, and Dexamethasone May Result in Both Hematologic and Metabolic Complete Response to Achieve Long-Term Progression Free Survival Among Patients Presenting with Extra-Medullary Disease: A European Myeloma Network Study (EMN19)

Meral Beksac, Tulin Tuglular, Francesca Gay, Roberto Mina, Eirini Katodritou, Ali Unal, Michele Cavo, Guner Hayri Ozsan, Vincent H.J. Van Der Velden, H. Berna Beverloo, Michael Vermeulen, Mark van Duin, Guldane Cengiz Seval, Omur Gokmen Sevindik, Serena Merante, Kyriaki Manousou, Pieter Sonneveld, Elena Zamagni, Evangelos Terpos
Journal: Blood
Blood (2023) 142 (Supplement 1): 1956.
https://doi.org/10.1182/blood-2023-178533
Published: 2023
Journal Articles

Salvage Autologous Stem Cell Transplant for the Treatment of First Relapse Multiple Myeloma: Evidence of Its Clinical Role from a Multicenter Italian Study

Silvia Mangiacavalli, Daniele Derudas, Angelo Belotti, Elena Zamagni, Laura Paris, Vincenzo Pavone, Roberto Mina, Nicola Di Renzo, Francesca Fazio, Giuseppe Tarantini, Sara Pezzatti, Gaetano Palumbo, Magda Marcatti, Jolanda Donatella Vincelli, Anna Maria Cafro, Antonietta Pia Falcone, Renato Zambello, Concetta Conticello, Rita Mazza, Francesco Di Raimondo, Alessandra Pompa, Enrica Antonia Martino, Fortunato Morabito, Paola Stefanoni, Gregorio Barila, Francesca Farina, Claudio Salvatore Cartia, Andrea Casson, Virginia Ferretti, Eleonora Fresi, Luca Arcaini, Maria Teresa Petrucci, Massimo Gentile
Journal: Blood
Blood (2023) 142 (Supplement 1): 2226.
https://doi.org/10.1182/blood-2023-181233
Published: 2023
Journal Articles

Lenalidomide Maintenance after VTD Induction and Autologous Stem Cell Transplantation: An Italian Real-Life Study of 558 Patients

Gregorio Barila, Angela Grassi, Concetta Conticello, Roberto Mina, Chiara Marcon, Francesca Fazio, Claudio Salvatore Cartia, Martina Tinelli, Maria Livia Del Giudice, Sofia Pilerci, Angelo Belotti, Anna Pascarella, Mariantonietta Tafuri, Serena Rocchi, Nicola Sgherza, Giuseppe Mele, Edoardo Scomazzon, Massimo Gentile, Marika Porrazzo, Norbert Pescosta, Anna Furlan, Massimiliano Arangio Febbo, Cristina Clissa, Andrea Casson, Rossella Ribolla, Antonio Maroccia, Chiara Lisi, Enrica Antonia Martino, Ombretta Annibali, Gabriele Buda, Elisabetta Antonioli, Silvia Mangiacavalli, Alberto Tosetto, Pellegrino Musto, Francesca Gay, Elena Zamagni, Maria Teresa Petrucci, Francesco Di Raimondo, Francesca Patriarca, Renato Zambello
Journal: Blood
Blood (2023) 142 (Supplement 1): 1959.
https://doi.org/10.1182/blood-2023-179922
Published: 2023
Journal Articles

The Use of Next Generation Flow in Multiple Myeloma Patients: A Preliminary Real-Life Multicenter MRD Harmonization Experience

Stefania Oliva, Elona Saraci, Valentina Trimarco, Marco Chiarini, Nunziatina Laura Parrinello, Renato Zambello, Iole Cordone, Tania Villanova, Serena Masi, Giovanni Rossi, Sara Marino, Anna Maria Triolo, Aldo Roccaro, Angelo Michele Carella, Francesco Buccisano, Angelo Belotti, Maria Irno Consalvo, Alessandra Romano, Alessia Tonini, Silvio Mercadante, Benedetto Bruno, Carolina Terragna, Elena Zamagni
Journal: Blood
Blood (2023) 142 (Supplement 1): 7161.
https://doi.org/10.1182/blood-2023-186536
Published: 2023
Journal Articles

MajesTEC-4 (EMN30): A Phase 3 Trial of Teclistamab + Lenalidomide Versus Lenalidomide Alone As Maintenance Therapy Following Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma

Elena Zamagni, Mario Boccadoro, Andrew Spencer, Michel Delforge, Donna E. Reece, Agoston Gyula Szabo, Hermann Einsele, Evangelos Terpos, Fredrik Schjesvold, Jelena Bila, Christoph Driessen, Meral Beksac, Gordon Cook, Cesar Rodriguez, Lixia Pei, Yingqi Shi, Caline Sakabedoyan, Jagaoda Jasielec, Himal Amin, Rachel Kobos, Pieter Sonneveld, Niels WCJ Van De Donk
Journal: Blood
Blood (2022) 140 (Supplement 1): 7289–7291.
https://doi.org/10.1182/blood-2022-159756
Published: 2022
Journal Articles

A Methodologically Updated De-Novo Extraction of Copy Number Signatures in Multiple Myeloma: Clinical Significance and Putative Aetiologies

Andrea Poletti, Stafano Delle Vedove, Gaia Mazzocchetti, Vincenza Solli, Ajsi Kanapari, Enrica Borsi, Marina Martello, Giovanni Martinelli, Silvia Armuzzi, Ilaria Vigliotta, Barbara Taurisano, Ignazia Pistis, Elena Zamagni, Michele Cavo, Carolina Terragna
Journal: Blood
Blood (2022) 140 (Supplement 1): 1559–1560.
https://doi.org/10.1182/blood-2022-164822
Published: 2022
Journal Articles

Real-World Treatment Patterns of Patients Initiating Third-Line Therapy in Relapsed or Refractory Multiple Myeloma in Europe

Moritz Lehne, K. Martin Kortuem, Elena Zamagni, Tim d'Estrube, Soham Shukla, Evi Zhuleku, Marco Ghiani, Maya Hanna, Ulf Maywald, Thomas Wilke, Sue Perera
Journal: Blood
Blood (2022) 140 (Supplement 1): 12485–12486.
https://doi.org/10.1182/blood-2022-163586
Published: 2022
Journal Articles

How I treat high-risk multiple myeloma

Elena Zamagni, Simona Barbato, Michele Cavo
Journal: Blood
Blood (2022) 139 (19): 2889–2903.
https://doi.org/10.1182/blood.2020008733
Published: 2022
Journal Articles

High Humoral Response after Anti-Sars-Cov-2 mRNA-Based Vaccines in Patients with Active Multiple Myeloma (MM) and Relationship with Disease Status/Line of Therapy

Katia Mancuso, Elena Zamagni, Vincenza Solli, Liliana Gabrielli, Lucia Pantani, Serena Rocchi, Ilaria Rizzello, Paola Tacchetti, Alessio Fusco, Gabriella De Cicco, Margherita Ursi, Marco Talarico, Emanuele Favero, Giuliana Nepoti, Barbara Ruffini, Carolina Terragna, Tiziana Lazzarotto, Pier Luigi Zinzani, Michele Cavo
Journal: Blood
Blood (2021) 138 (Supplement 1): 4732.
https://doi.org/10.1182/blood-2021-150266
Published: 2021
Journal Articles

Efficacy and Safety of Daratumumab with Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma and Severe Renal Impairment or on Dialysis: Final Analysis of the Phase 2 Dare Study

Efstathios Kastritis, Evangelos Terpos, Argiris Symeonidis, Sosana Delimpasi, Michele Cavo, Elena Zamagni, Eirini Katodritou, Elena Rivolti, Marie-Christine Kyrtsonis, Maria Roussou, Despina Fotiou, Evdoxia Hatjiharissi, Nikolaos Kanellias, Magdalini Migkou, Alexandros Leonidakis, Kyriaki Manousou, Maria Gavriatopoulou, Meletios A. Dimopoulos
Journal: Blood
Blood (2021) 138 (Supplement 1): 2729.
https://doi.org/10.1182/blood-2021-153075
Published: 2021
Journal Articles

HORIZON (OP-106): Melflufen Plus Dexamethasone (dex) in 55 Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM) with Extramedullary Disease (EMD)-Subgroup Analysis

Paul G. Richardson, MD, María-Victoria Mateos, MD PhD, Albert Oriol, Alessandra Larocca, Michele Cavo, Paula Rodríguez-Otero, MD PhD, Xavier Leleu, MD, Maxim Norkin, MD PhD, Omar Nadeem, MD, John W. Hiemenz, MD, Hani Hassoun, MD, Cyrille Touzeau, Adrián Alegre Amor, MD PhD, Agne Paner, MD, Christopher Maisel, MD, Amitabha Mazumder, MD, Anastasios Raptis, MD, Noemí Puig, MD PhD, Elena Zamagni, Marcus Thuresson, PhD, Johan Harmenberg, MD PhD, Olof Harlin, VMD, PhD, Joan Blade Creixenti
Journal: Blood
Blood (2020) 136 (Supplement 1): 15–17.
https://doi.org/10.1182/blood-2020-137118
Published: 2020
Journal Articles

Impact of Imaging FDG-PET/CT Minimal Residual Disease Assessment on Outcomes and Matching with Bone Marrow Techniques in Newly Diagnosed Transplant Eligible Multiple Myeloma (MM) Patients: Results of the Phase II Randomized Forte Trial

Elena Zamagni, Cristina Nanni, MD, Francesca Gay, MD, Luca Dozza, MSc, Delia Rota Scalabrini, Mattia D'Agostino, MD, Rossella Ribolla, MD, Monica Galli, Manuela Racca, MD, Renato Zambello, Elena Rivolti, MD, Domenico Albano, MD, Annibale Versari, MD, Mariella Grasso, Rossella Troia, PharmD, Antonio Spadano, Francesca Patriarca, Marina Ruggeri, Marco Rensi, MD, Anna Pascarella, Pietro Zucchetta, MD, Paola Tacchetti, Stefano Fanti, MD PhD, Mario Boccadoro, Michele Cavo, Pellegrino Musto, Stefania Oliva
Journal: Blood
Blood (2020) 136 (Supplement 1): 27–28.
https://doi.org/10.1182/blood-2020-137412
Published: 2020
Journal Articles

High-Risk Multiple Myeloma Patients Are Missed without Gene Expression Profiling

Martin H Van Vliet, Yan-Ting Chen, PhD, Erik H Van Beers, PhD, Rowan Kuiper, PhD, Erik T. Valent, PhD, Marieke Spaan, MSc, Carolina Terragna, Elena Zamagni, Michele Cavo, Stefania Oliva, Alessandra Larocca, Torsten Haferlach, MD, Wee-Joo Chng, MBBS, PhD FRCPath, FRCP, Anders Waage, MD PhD, M Duin, Pieter Sonneveld, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 23–24.
https://doi.org/10.1182/blood-2020-137389
Published: 2020
Journal Articles

Impact of Minimal Residual Disease (MRD) By Multiparameter Flow Cytometry (MFC) and Next-Generation Sequencing (NGS) on Outcome: Results of Newly Diagnosed Transplant-Eligible Multiple Myeloma (MM) Patients Enrolled in the Forte Trial

Stefania Oliva, Elisa Genuardi, Maria Teresa Petrucci, Mattia D'Agostino, MD, Daniel Auclair, Antonio Spadano, Allison P. Jacob, Michele Cea, Luca De Rosa, Alessandro Gozzetti, Marina Ruggeri, Andrea Capra, Milena Gilestro, Norbert Pescosta, Angelo D. Palmas, Agostina Siniscalchi, Ilan R. Kirsch, Paolo Corradini, Pellegrino Musto, Mario Boccadoro, Elena Zamagni, Francesca Gay, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 44–45.
https://doi.org/10.1182/blood-2020-137351
Published: 2020
Journal Articles

Survival Analysis of Newly Diagnosed Transplant-Eligible Multiple Myeloma Patients in the Randomized Forte Trial

Francesca Gay, MD, Pellegrino Musto, Delia Rota Scalabrini, Monica Galli, Angelo Belotti, Elena Zamagni, Luca Bertamini, MD, Renato Zambello, Micol Quaresima, Giovanni De Sabbata, Giuseppe Pietrantuono, Mattia D'Agostino, MD, Daniela Oddolo, Andrea Capra, Anna Marina Liberati, Salvatore Palmieri, Franco Narni, Massimo Offidani, Michele Cavo, Mario Boccadoro
Journal: Blood
Blood (2020) 136 (Supplement 1): 35–37.
https://doi.org/10.1182/blood-2020-136907
Published: 2020
Journal Articles

Upfront Autologous Hematopoietic Stem-Cell Transplantation Improves Overall Survival in Comparison with Bortezomib-Based Intensification Therapy in Newly Diagnosed Multiple Myeloma: Long-Term Follow-up Analysis of the Randomized Phase 3 EMN02/HO95 Study

Michele Cavo, Francesca Gay, MD, Meral Beksac, MD, Meletios A Dimopoulos, Lucia Pantani, MD PhD, Maria Teresa Petrucci, Luca Dozza, MSc, Bronno Van Der Holt, PhD, Sonja Zweegman, MDPhD, Elena Zamagni, Giuseppe A. Palumbo, MD PhD, Francesca Patriarca, Monica Galli, Vladimir Maisnar, MD PhD MBA, Markus Hansson, MD, Angelo Belotti, Ludek Pour, MD, Paula F Ypma, MD PhD, Mariella Grasso, Sandra Croockewit, MD, Massimo Offidani, Renato Zambello, Anna Marina Liberati, MD, Niels Frost Andersen, MD PhD, Annemiek Broyl, MD PhD, Rossella Troia, PharmD, Pellegrino Musto, Heinz Ludwig, MD, Anna Maria Morelli, MD, Roman Hajek, MD, Christoph Driessen, MD, Anders Waage, MD PhD, Peter Gimsing, DO, PhD, Ulf-Henrik Mellqvist, MD PhD, Thilo Zander, MD, Mario Boccadoro, Pieter Sonneveld, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-137575
Published: 2020
Journal Articles

A New Risk Stratification Model (R2-ISS) in Newly Diagnosed Multiple Myeloma: Analysis of Mature Data from 7077 Patients Collected By European Myeloma Network within Harmony Big Data Platform

Mattia D'Agostino, MD, Juan-José Lahuerta, MD PhD, Ruth Wester, MD, Anders Waage, MD PhD, Uta Bertsch, Elena Zamagni, Maria-Victoria Mateos, MD PhD, Alessandra Larocca, Daniele Dall'Olio, Niels W. C. J. van de Donk, David Cairns, MSc, PhD, Serena Rocchi, Hans Salwender, MD, Joan Blade Creixenti, Bronno van der Holt, PhD, Castellani Gastone, Giovannino Ciccone, Andrea Capra, Jan Dürig, MD, Sara Bringhen, MD, Sonja Zweegman, MDPhD, Michele Cavo, Hartmut Goldschmidt, MD, Gordon Cook, MB ChB, PhD, Jesus Maria Hernández-Rivas, MD PhD, Jesus F. San-Miguel, MD PhD, Mario Boccadoro, Pieter Sonneveld, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 34–37.
https://doi.org/10.1182/blood-2020-137021
Published: 2020
Journal Articles

Daratumumab with Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma and Severe Renal Impairment: Results on Efficacy and Safety of the Phase 2 Dare Study

Efstathios Kastritis, MD, Evangelos Terpos, MDPhD, Argiris Symeonidis, MD PhD, Sosana Delimpasi, MD, Michele Cavo, Elena Zamagni, Eirini Katodritou, MD, Elena Rivolti, MD, Marie-Christine Kyrtsonis, MD, Maria Gavriatopoulou, Maria Roussou, MD, Despina Fotiou, MD, Evdoxia Hatjiharissi, MD, Nikolaos Kanellias, MD, Magdalini Migkou, Meletios A Dimopoulos
Journal: Blood
Blood (2020) 136 (Supplement 1): 48–49.
https://doi.org/10.1182/blood-2020-140322
Published: 2020
Journal Articles

Validation and Improvement Opportunities of the Revised International Staging System for Multiple Myeloma: An Analysis on Mature Data from European Clinical Trials within the Harmony Big Data Platform

Mattia D'Agostino, MD, Anders Waage, MD PhD, Juan-José Lahuerta, MD PhD, Uta Bertsch, Elena Zamagni, MD, Lars Bullinger, Alessandra Larocca, Maria-Victoria Mateos, Niels W. C. J. Van De Donk, Hans Jürgen Salwender, MD, Joan Bladé, MD, Bronno van der Holt, PhD, Paola Tacchetti, Giovannino Ciccone, Sonja Zweegman, Hartmut Goldschmidt, Michele Cavo, Jesús San-Miguel, Pieter Sonneveld, Mario Boccadoro, Jesús María Hernández-Rivas, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1773.
https://doi.org/10.1182/blood-2019-124321
Published: 2019
Journal Articles

Negative Selective Pressure Exerted By Maintenance Therapy Promotes the Extinction of Sub-Clones Carrying High-Risk Lesions in Multiple Myeloma

Carolina Terragna, Andrea Poletti, Vincenza Solli, Marina Martello, Enrica Borsi, Lucia Pantani, Agboyi Lakpo, Luca Cifarelli, Silvia Armuzzi, Rosalinda Termini, Elena Zamagni, MD, Paola Tacchetti, Serena Rocchi, Katia Mancuso, Serena Rocchi, Ilaria Rizzello, Giulia Marzocchi, Nicoletta Testoni, Luca Dozza, Maria Teresa Petrucci, Anna Marina Liberati, Giuseppe Rossi, Mario Boccadoro, Michele Cavo
Journal: Blood
Blood (2019) 134 (Supplement_1): 1778.
https://doi.org/10.1182/blood-2019-127799
Published: 2019